Harvard Bioscience

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell HBIO and other ETFs, options, and stocks.

About HBIO

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. 

CEO
John D. Duke
CEOJohn D. Duke
Employees
355
Employees355
Headquarters
Holliston, Massachusetts
HeadquartersHolliston, Massachusetts
Founded
1901
Founded1901
Employees
355
Employees355

HBIO Key Statistics

Market cap
23.30M
Market cap23.30M
Price-Earnings ratio
-0.38
Price-Earnings ratio-0.38
Dividend yield
Dividend yield
Average volume
488.14K
Average volume488.14K
High today
$0.5348
High today$0.5348
Low today
$0.4794
Low today$0.4794
Open price
$0.509
Open price$0.509
Volume
760.10K
Volume760.10K
52 Week high
$3.27
52 Week high$3.27
52 Week low
$0.2813
52 Week low$0.2813

HBIO News

Seeking Alpha 4d
Harvard Bioscience outlines $19M–$21M Q3 revenue target as debt refinancing advances and product adoption accelerates

Earnings Call Insights Harvard Bioscience outlines $19M–$21M Q3 revenue target as debt refinancing advances and product adoption accelerates Aug. 11, 2025 9:54...

Harvard Bioscience outlines $19M–$21M Q3 revenue target as debt refinancing advances and product adoption accelerates

People also own

Based on the portfolios of people who own HBIO. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.